A pharmaceutical composition including N,N,N',N'-tetrakis-(2- pyridylmethyl)-ethylenediamine (TPEN) or a pharmaceutically acceptable salt thereof, an alginate compound, and a pharmaceutically acceptable carrier. The pharmaceutical composition is useful for the treatment of hypoxia-related diseases.